Inappropriate Discharges by Fourth Generation Implantable Cardioverter Defibrillators in Patients With Ventricular Arrhythmias

スポンサーリンク

概要

• 論文の詳細を見る

• The study prospectively investigated the incidence, cause ane efficient management of inappropriate discharge by the fourth generation implantable cardioverter-defibrillator(ICD)system in 45 patients(mean age, 57±16 years). During the follow-up period of 27±17 months, 18 patients(40%)experienced one or more inappropriate therapies: sinus and supraventricular tachycardia(15 patients)and T wave oversensing(3 patients). In the 15 patients, re-programming of the tachycardia detection interval and/or additional treatment with β-blocking agents were effective. In the 3 patients with T wave oversensing, the arrythmia was associated with an increase in T wave amplitude, change in T wave morphology and decreased R wave amplitude, and re-programming of the sensitivity of the local electrogram or changing the number of intervals to detect ventricular tachycardia decreased the number of inappropriate discharges in all 3 patients. In conclusion, inappropriate therapies are common problems in patients treated with the fourth generation ICD system, but most of them can be resolved using the dualchamber ICD system. However, in patients with T-wave oversensing, it is difficult to avoid inappropriate discharge completely, even if the dual-chamber ICD system is implanted.

• 社団法人日本循環器学会の論文
• 2001-10-20

著者

• Aizawa Yoshifusa

  First Department of Internal Medicine, Niigata University School of Medicine

• Furushima Hiroshi

  First Department of Internal Medicine, Niigata University School of Medicine

• Furushima Hiroshi

  First Department Of Internal Medicine Niigata University School Of Medicine

• Chinushi Masaomi

  First Department Of Internal Medicine Niigata University School Of Medicine

• Watanabe Hiroshi

  Department of Cardiology, Niigata City General Hospital

• Washizuka Takashi

  First Department of Internal Medicine, Division of Cardiology, Niigata University School of Medicine

• Kasai Hidehiro

  The First Department of Internal Medicine, Niigata University School of Medicine

• HOSAKA Yukio

  First Department of Internal Medicine, Niigata University School of Medicine

• Hosaka Yukio

  First Department Of Internal Medicine Niigata University School Of Medicine

• Washizuka Takashi

  First Department Of Internal Medicine Niigata University School Of Medicine

• Watanabe Hiroshi

  First Department of Internal Medicine Niigata University Hospital

• Kasai Hidehiro

  The First Department Of Internal Medicine Niigata University School Of Medicine

• Hosaka Yukio

  Division Of Cardiology Niigata University Graduate School Of Medical And Dental Science

• Abe Akira

  First Department of Internal Medicine, Niigata Universaity School of Medicine

• Abe Akira

  The First Department Of Internal Medicine Niigata University School Of Medicine

• Tagawa Minoru

  Divisions Of Cardiology Niigata University Graduate School Of Medical And Dental Sciences

• Hayashi Junichi

  Department of Internal Medicine, School of Medicine, Keio University

• Washizuka Takashi

  Division Of Cardiology Niigata University Graduate School Of Medical And Dental Science

• Kasai Hidehiro

  First Department Of Internal Medicine Niigata University School Of Medicine

• Yamashita Fumio

  First Department of Internal Medicine Niigata University Medical & Dental Hospital

• Tagawa Minoru

  First Department of Internal Medicine, Niigata University School of Medicine

• Yamashita Fumio

  Divisions Of Cardiology Niigata University Graduate School Of Medical And Dental Sciences

• Hayashi Junichi

  Department Of Thoracic And Cardiovascular Surgery Niigata Universiy Hospital

• Watanabe Hiroshi

  Division Of Cardiology Niigata University Graduate School Of Medical And Dental Science

• Aizawa Yoshifusa

  First Department Of Internal Medicine Niigata Universaity School Of Medicine

• Hayashi Junichi

  Department Of General Medicine School Of Medicine Kyorin University

• Abe Akira

  First Department Of Internal Medicine Niigata University School Of Medicine

• Hayashi Junichi

  Department Of General Medicine Kyorin University School Of Medicine

• Watanabe Hiroshi

  Department Of Applied Chemistry And Bioengineering Graduate School Of Engineering Osaka City Univers

• WASHIZUKA Takashi

  First Department of Internal Medecine, Niigata University School of Medicine, Niigata, Japan.

• AIZAWA Yoshifusa

  First Department of Internal Medecine, Niigata University School of Medicine, Niigata, Japan.

関連論文

• PJ-004 Clinical and ECG Characteristics as a Predictor of Recurrence of Ventricular Tachyarrhythmia (VTA) in Patients with Hypertrophic Cardiomyopathy (HCM)(PJ001,Arrhythmia, Others (Clinical/Pathophysiology) 1 (A),Poster Session (Japanese),The 73rd Annua
• 14-3-3 Protein Protects Against Cardiac Endoplasmic Reticulum Stress (ERS) and ERS-Initiated Apoptosis in Experimental Diabetes
• Japanese Randomized Trial for Investigation of a Combined Therapy of Amiodarone and Implantable Cardioverter Defibrillator in Patients With Ventricular Tachycardia and Fibrillation : The Nippon ICD Plus Pharmacologic Option Necessity (NIPPON) Study Design
• Factors Predicting Mortality in Patients after Myocardial Infarction Caused by Left Main Coronary Artery Occlusion : Significance of ST Segment Elevation in Both aVR and aVL Leads
• Potential Candidates for Cardiac Resynchronization Therapy in Japanese Patients With Idiopathic Dilated Cardiomyopathy : A Niigata Multicenter Study of DCM
• Primary Concerns during Daily Life in Patients with ICD and their Families (Role of ICD Discharge for Quality of Life)
• Comparison of triggering modes and therapeutic effect of nicorandil for ventricular tachyarrhythmia in canine models of LQT2 and LQT3
• Tridimensional analysis of onset mode and arrhythmogenesis of discordant QT/T alternans in long QT syndrome
• Discrepancy between Inducibility of Ventricular Tachycardia and Activity of Cardiac Sarcoidosis - Requirement of Defibrillator Implantation for the Inactive Stage of Cardiac Sarcoidosis -
• Role of α_1-Blockade in Congenital Long QT Syndrome : Investigation by Exercise Stress Test
• Significance of Early Onset and Progressive Increase of Activation Delay During Premature Stimulation in Brugada Syndrome
• Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy
• Fenofibrate, a Peroxisome Proliferator-Activated Receptor α Activator, Suppresses Experimental Autoimmune Myocarditis by Stimulating the Interleukin-10 Pathway in Rats
• PJ-692 Role of Faster Pacing and Magnesium (Mg) for the Treatment of Torsade de pointes (Tdp) Associated with Intravenous Amiodarone Administration(PJ116,Ventricular Arrhythmia (Clinical/Pathophysiology) (A),Poster Session (Japanese),The 73rd Annual Scien
• PJ-688 The Abnormality of QT/RR Relationship in Brugada Syndrome and Idiopathic Ventricular Fibrillation without Prominent J-wave(PJ116,Ventricular Arrhythmia (Clinical/Pathophysiology) (A),Poster Session (Japanese),The 73rd Annual Scientific Meeting of T
• PJ-555 Distribution of Defibrillation Threshold (DFT) in Patients Treated with Implantable Cardioverter-Defibrillators (ICD) : Incidence and Characteristics of High DFT Patients(PJ093,Ventricular Arrhythmia (Clinical/Diagnosis/Treatment) 2 (A),Poster Sess
• PJ-089 Characteristics of the Subsequent Recurrence of Ventricular Tachyarrhythmia in Patients under ICD Therapy, Concern of Driving(PJ015,ICD (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• PE-105 Exercise-induced QT Interval Prolongation and Its Relation to the Cardiac Events in Long QT Syndrome (LQTS) Carrying KCNQ1-Mutations(PE018,Arrhythmia, Others (Clinical/Pathophysiology) (A),Poster Session (English),The 73rd Annual Scientific Meeting
• 4 Role of Antiarrhythmic Drugs in Preventing Sudden Cardiac Death(Fighting Cardiac Sudden Death: Efficacy and Future,Roundtable Discussion 8 (RT-8) (A),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• 4 Relationship between Drug-Induced QT Prolongation and Bradycardia Dependent QT Prolongation : Usefulness for Risk Factors of Drug-induced Long QT Syndrome(Proarrhythmic Risk of Drugs and Their Evaluation,Symposium 7 (SY-07) (I),The 73rd Annual Scientifi
• Preservation of Renal Function in Response to Cardiac Resynchronization Therapy
• PJ-789 Measurement of defibrillation threshold in the patients treated with implantable cardioverter-defibrillator (ICD)(Arrhythmia, therapy(22)(A),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-694 Indication of ICD treatment as primary prevention of sudden cardiac death in Japanese patients with dilated cardiomyopathy(Heart failure, clinical(19)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Societ
• Saphenous Vein Graft Shrinkage as a Mechanism of Stenosis Soon After Bypass Surgery
• PJ-294 Shortening of QT Interval by Mexiletine and It's Clinical Use in LQTl and LQT2(Arrhythmia, therapy-19, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-097 Intracoronary Acetylcholine (Ach) Induces a Greater QT Interval Prolongation and Torsade de Points (TdP) in LQT2 Than LQT1(Autonomic nervous system-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Nifekalant Hydrochloride Suppresses Severe Electrical Storm in Patients With Malignant Ventricular Tachyarrhythmias
• Relationship Between Clinical Characteristics and Conduction Delay in the RVOT in Brugada Syndrome : Investigation of Signal-Averaged ECG in Precordial Leads(ECG/Body Surface Potential Mapping/Holter 2 (A), The 69th Annual Scientific Meeting of the Japane
• Role of Combined Medication Therapy for ICD Patients : Prognosis and ICD Discharge(Sudden Cardiac Death (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-429 Antiarrhythmic effects of magnesium sulfate for ventricular tachyarrhythmia developed under the condition of QT interval prolongation(ECG/Body Surface Potential Mapping/Holter 6 (A) : OJ52)(Oral Presentation (Japanese))
• Dose-Response Effects of Bepridil in Patients With Persistent Atrial Fibrillation Monitored With Transtelephonic Electrocardiograms : A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study (J-BAF Study)
• Acute Pulmonary Thromboembolism Induced by Prophylactic Heparin Use and a Heparin-Coated Catheter : A Case of Heparin-Induced Thrombocytopenia and Thrombosis Syndrome
• Regulation of Endothelial Nitric Oxide Synthase and Endothelin-1 Expression by Fluvastatin in Human Vascular Endothelial Cells
• The Usefulness of Holter Monitoring in Selecting Pharmacologic Therapy for Patients With Sustained Monomorphic Ventricular Tachycardia : Studies in Patients in Whom No Effective Pharmacologic Therapy Could be Determined by Electrophysiologic Study
• NET Na/K FLUX RATIO IN THE ERYTHROCYTE OF JAPANESE : PROCEEDINGS OF THE 47th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY : Hypertension
• Serum Hepcidin-20 is Elevated during the Acute Phase of Myocardial Infarction
• PE-353 Comparative Effects of Torasemide and Furosemide in Rats with Chronic Heart Hailure after Autoimmune Myocarditis(PE059,Heart Failure (Treatment) 2 (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• -P155- Evaluation of Ventricular Vulnerability during Atrial Defibrillation through Implanted Transvenous Catheters in The Sterile Pericarditis Model(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
• Requirements of Non-pharmacologic Interventions in the Treatmrnt of Recurrent Sustained Ventricular Tachycardia : 53th Annual Scientific Session of the Japanese Circulation Society
• CONDUCTION THROUGH THE REENTRANT CIRCUIT IN RECURRENT SUSTAINED VENTRICULAR TACHYCARDIA EVALUATED BY USE OF TRANSIENT ENTRAINMENT
• Involvement of Mast Cells in the Development of Fibrosis in Rats with Postmyocarditis Dilated Cardiomyopathy(Miscellaneous)
• Inactivation of 14-3-3 Protein Exacerbates Cardiac Hypertrophy and Fibrosis through Enhanced Expression of Protein Kinase C β2 in Experimental Diabetes(Biochemistry/Molecular Biology)
• Expression of the TCL1 Gene at 14q32 in B-Cell Malignancies but Not in Adult T-Cell Leukemia
• VENTRICULAR TACHYCARDIA WITH TWO POSSIBLE EXITS FROM ONE RE-ENTRANT CIRCUIT
• OE-329 Ventricular tachyarrhytmia developed during treatment with class III antiarrhythmic drugs : arrhythmogenesis of slow heart rate and sympathetic nerve activity(Arrhythmia, Pharmacological Therapy 4 (A): OE42)(Oral Presentation (English))
• The Efficacy of DL-Sotalol in Reentrant Ventricular Tachycardia with Special Reference to the Width of the Zone of Entrainment
• Suppression of Myocardial Inflammation Using Suramin, A Growth Factor Blocker
• Changes in the Occurrence of Mechanical Alternans After Long-Term β-Blocker Therapy in Patients With Chronic Heart Failure
• Abnormal fatty acid matabolism in patients with coronary vasospasm
• Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiency
• Electrophysiologic Parameters to Predict Clinical Recurrence of Ventricular Tachycardia in Patients Under Electrophysiologic Study-Guided Effective Pharmacological Therapy
• P013 Effect of Digoxin on Induction of Ventricular Arrhythmias after Atrial Defibrillation Shocks through Implanted Transvenous Catheter Electrodes in The Sterile Pericarditis Model of Atrial Fibrillation.
• P008 Characteristics of Excitable Gap in the Atrial Flutter Reentrant Circuit in the Canine Sterile Pericarditis Model.
• Recovery From Complete Atrioventricular Block Caused by Idiopathic Giant Cell Myocarditis After Corticosteroid Therapy
• PJ-049 A Comparison of Dilated Cardiomyopathy with Hypertrophic Cardiomyopathy in Efficacy of Implantable Cardioverter-Defibrillator(Arrhythmia, therapy-14, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OE-213 Evaluation of Adipocytokines, Proinflammatory Cytokines, and Inflammatory Markers in Coronary Sinus and Hepatic Venous Blood(Coronary circulation, basic/clinical-1 (IHD) OE36,Oral Presentation (English),The 70th Anniversary Annual Scientific Meetin
• OE-221 Role of Cardiac Resynchronization Therapy on Renal Function(Kidney/Renal circulation(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• Inappropriate Discharges by Fourth Generation Implantable Cardioverter Defibrillators in Patients With Ventricular Arrhythmias
• Development of Ventricular Fibrillations With Different Characteristics in the Local Electrocardiogram : Large and Small Amplitude of Activation, and its Implication for Implantable Cardioverter Defibrillator Treatment
• Shoshin Beriberi With Vasospastic Angina Pectoris : Possible Mechanism of Mid-Ventricular Obstruction
• Left Ventricular Free Wall Rupture in Acute Fulminant Myocarditis During Long-Term Cardiopulmonary Support
• 0521 Increased QTc dispersion in patients with ventricular fibrillation in chronic phase of acute myocardial infarction
• Difference in Ventricular Fibrillation interval between Structural Heart Disease and Brugada Syndrome : Role of Sotalol Treatmentand Defibrillation Threshold
• Severe Electrical Storm in Patients with Implantable CardioverterDefibrillators (ICD) : Does It Predict Poor Prognosis?
• Long-Term Outcomes of EP-Guided Sotalol Treatment for Sustained Ventricular Tachyarrhythmias
• RADIOFREQUENCY CURRENT CATHETER ABLATION FOR VENTRICULAR TACHYCARDIA
• The Role of Rac1 in β-adrenergic Receptor Stimulated Apoptosis in Adult Rat Ventricular Myocyte(Apoptosis/Necrosis/Regeneration 3 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• OE-322 Comparative Effects of V2 Receptor Antagonist Tolvaptan and the Loop Diuretic Furosemide in Rats with Heart Failure after Autoimmune Myocarditis(OE55,Heart Failure (Treatment) 2 (M),Oral Presentation (English),The 73rd Annual Scientific Meeting of
• A New Scoring System to Predict the Efficacy of Steroid Therapy for Patients With Active Myocarditis : A Retrospective Study
• Effects of Angiotensin Receptor Blocker on Oxidative Stress and Cardio-Renal Function in Streptozotocin-Induced Diabetic Rats
• Effects of Edaravone in Heart of Aged Rats after Cerebral Ischemia-Reperfusion Injury(Pharmacology)
• Edaravone Inhibits JNK-c-Jun Pathway and Restores Anti-oxidative Defense after Ischemia-Reperfusion Injury in Aged Rats(Pharmacology)
• Cardiac Fatty Acid Metabolism Was Impaired and Delayed in Peroxisome Proliferator Activated Receptor (PPAR) alpha-Null Mice
• Amiodarone Suppressed Left Ventricular Remodeling and Improved Cardiac Function and Sympathetic Function in Chronic Heart Failure after Autoimmune Myocarditis
• Hypertrophic Cardiomyopathy With Type I CD36 Deficiency
• Non-Pharmacological Management of Ventricular Tachycardia(Ventricular Tachycardia/Fibrillation)
• Clinical characteristics of patients with inappropriate implantable cardioverter defibrillator(ICD)therapies : indication for dual-chamber ICD for sinus tachycardia
• Severe Starvation Hypoglycemia and Congestive Heart Failure Induced by Thyroid Crisis, with Accidentally Induced Severe Liver Dysfunction and Disseminated Intravascular Coagulation
• Effect of gene transfer of cytotoxic T lymphocyte associated molecule 4 -lgG Fc chimera (CTLA4lg) by electroporation against experimental autoimmune myocarditis
• Intramural Arrhythmogenesis of ECG Phenomenon of Prolonged QT Interval, Short-Long Cardiac Cycle and T Wave Alternans in Long QT Syndrome
• Arrhythmogenesis of Sympathetic Activity Related Ventricular Tachyarrhythmias in Type 3 Long QT Syndrome (LQT3)
• -157-REGULATION OF HEMODYNAMICS IN MAN (1st Report). DYSFUNCTION OF ADRENERGIC NERVE AS A POSSIBLE CAUSE OF HYPOTENSION IN PATIENTS ON HEMODIALYSIS : Kidney : PROCEEDINGS OF THE 42nd ANNUAL MEETING OF THE JAPANESE CIRCULATION SOCIETY
• Demonstration of Transient Entrainment in Monomorphic Sustained Ventricular Tachycardia Associated With Cardiac Sarcoidosis
• Curcumin Ameliorates Cardiac Inflammation in Rats with Autoimmune Myocarditis
• A Novel Program to Accurately Quantify Infarction Volume by ^Tc MIBI SPECT, and Its Application for Re-Analyzing the Effect of Erythropoietin Administration in Patients With Acute Myocardial Infarction : A Randomized Controlled Pilot Trial of the EPO
• Reduction by tranexamic acid of glomerular hypertrophy and increased glomerular expression of extracellular matrix components induced by streptozotocin diabetes in rats
• Modulation of gene expression of ionic channels in rat heart by thyroid hormone
• 14-3-3 Protein Protects Against Cardiac Endoplasmic Reticulum Stress (ERS) and ERS-Initiated Apoptosis in Experimental Diabetes
• Correlation Between the Effective Refractory Period and Activation-Recovery Interval Calculated From the Intracardiac Unipolar Electrogram of Humans With and Without dl-Sotalol Treatment
• Magnesium Treatment for Drug-Induced QT Prolongation
• A Comparison of Electrophysiologic Properties between Responders and Non-responders to DL-sotalol among Patients with Ventricular Tachyarrhythmia. Importance of the Lack of a Reverse Use-dependent Effect on Ventricular Refractoriness to Responders. : Impo
• Use-dependent Electrophysiologic Effects of DL-sotalol and Modulation by Isoproterenol in the Human Ventricle.
• Role of Sotalol and Nifekalant Therapy in Patients with Life-Threatening Ventricular Tachyarrhythmia
• Nicorandil Suppresses a Hump on the Monophasic Action Potential and Torsade de Pointes in a Patient with Idiopathic Long QT Syndrome.
• Stroke volume estimated at aortic root in M-mode echocardiography.
• Comparison of Electrophysiologic Effects of Intravenous E-4031 and MS-551, Novel Class III Antiarrhythmic Agents, in Patients with Ventricular Tachyarrhythmias.
• Electrophysiologic Effects of Intravenous MS-551, a Novel Class III Antiarrhythmic Agent, on Human Atrium and Ventricle.
• Intracoronary Acetylcholine-induced Prolongation of Monophasic Action Potential in Long QT Syndrome.
• Both Low and High Energy Cardioversion Induced Accelerated Ventricular Tachycardia in a Patient Treated with an Implantable Cardioverter Defibrillator.
• Comparative Electrophysiologic Findings between Responders and Nonresponders to Class III Antiarrhythmic Drugs among Patients with Ventricular Tachyarrhythmia.

もっと見る 閉じる

スポンサーリンク